FALS
Showing 1 - 24 of 24
The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis Study
Recruiting
- Amyotrophic Lateral Sclerosis
-
Miami, FloridaUniversity of Miami
Apr 5, 2022
Motor Neuron Disease, Amyotrophic Lateral Sclerosis Trial in Berlin
Recruiting
- Motor Neuron Disease, Amyotrophic Lateral Sclerosis
-
Berlin, GermanyCenter for ALS and other motor neuron disorders, Charité - Unive
May 2, 2023
Macrophages From Patients Affected by ALS or Other Related Motor
Recruiting
- Amyotrophic Lateral Sclerosis
-
Paris, FranceDépartement de Neurologie, Hôpital de la Pitié-Salpêtrière
May 24, 2022
Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy
Enrolling by invitation
- Amyotrophic Lateral Sclerosis
- +9 more
-
Worcester, MassachusettsUniversity of Massachusetts Medical School
May 16, 2022
Amyotrophic Lateral Sclerosis Trial in Beijing (Amyotrophic Lateral Sclerosis)
Not yet recruiting
- Amyotrophic Lateral Sclerosis
- Amyotrophic Lateral Sclerosis
-
Beijing, ChinaBeijing Tiantan Hospital
May 28, 2023
Amyotrophic Lateral Sclerosis (ALS) Families Project
Recruiting
- ALS
-
New York, New YorkColumbia University
Oct 20, 2021
SOD1 Kinetics Measurements in ALS Patients
Suspended
- Amyotrophic Lateral Sclerosis, Familial
- Amyotrophic Lateral Sclerosis, Sporadic
-
Boston, Massachusetts
- +1 more
Apr 11, 2022
Cannabis Dependence Trial in New Haven (Contingency Management + Motivational Interviewing)
Completed
- Cannabis Dependence
- Contingency Management + Motivational Interviewing
-
New Haven, ConnecticutThe Yale Stress Center: Yale University
Nov 4, 2021
Overweight, Obesity Trial in United States
Recruiting
- Overweight
- Obesity
-
Little Rock, Arkansas
- +27 more
Feb 11, 2022
Parkinson Disease, Sleep Disorder, Circadian Rhythm Disorders Trial in Suzhou (Bright light box, Dim Light box)
Recruiting
- Parkinson Disease
- +2 more
- Bright light box
- Dim Light box
-
Suzhou, Jiangsu, ChinaDepartment of Neurology, Second Affiliated Hospital of Soochow U
Nov 10, 2023
Amyotrophic Lateral Sclerosis Trial in Italy (Rapamycin, Placebo Oral Tablet)
Completed
- Amyotrophic Lateral Sclerosis
- Rapamycin
- Placebo Oral Tablet
-
Genova, Italy
- +7 more
Aug 9, 2022
Moderate to Severe Opioid Use Disorder Trial in Canada (Extended Release Subcutaneous Buprenorphine, Immediate Release
Not yet recruiting
- Moderate to Severe Opioid Use Disorder
- Extended Release Subcutaneous Buprenorphine
- Immediate Release Sublingual Buprenorphine
-
Barrie, Ontario, Canada
- +4 more
Oct 20, 2022
Circulating Biomarker for Amyotrophic Lateral Sclerosis (ALS)
Recruiting
- Amyotrophic Lateral Sclerosis (ALS)
-
Pozzilli, ItalyIRCCS Neuromed
May 18, 2022
Mental Health Wellness 1 Trial in Omaha (FFL + Cognitive Behavioral Therapy, Fathers for a Lifetime (FFL) only)
Completed
- Mental Health Wellness 1
- FFL + Cognitive Behavioral Therapy
- Fathers for a Lifetime (FFL) only
-
Omaha, NebraskaCharles Drew Health Center, Inc.
Jan 19, 2021
l Modifications ofCritical Protein Implicated in Amyotrophic
Completed
- ALS
-
Chapel Hill, North CarolinaUNC Neurology ALS clinic
Oct 16, 2018
Familial Amyotrophic Lateral Sclerosis Trial in Lexington (Betamethasone sodium phosphate/betamethasone acetate (Celestone®
Completed
- Familial Amyotrophic Lateral Sclerosis
- Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for four days
-
Lexington, KentuckyUniversity of Kentucky Medical Center
Feb 9, 2020
Amyotrophic Lateral Sclerosis Trial in Kuala Lumpur (Tocotrienols, Placebo)
Unknown status
- Amyotrophic Lateral Sclerosis
- Tocotrienols
- Placebo
-
Kuala Lumpur, MalaysiaClinical Investigation Centre (CIC)
Oct 23, 2019
Familial Amyotrophic Lateral Sclerosis Trial in Worldwide (Pyrimethamine)
Completed
- Familial Amyotrophic Lateral Sclerosis
-
New York, New York
- +4 more
May 19, 2017
Laryngospasm Trial in Basel (NaCl 0,9%)
Completed
- Laryngospasm
- NaCl 0,9%
-
Basel, SwitzerlandUniversity children's hospital beider Basel
Oct 29, 2015
Cocaine Dependence Trial in United States (Buspirone, Placebo)
Depression, Substance-Related Disorders Trial in Union City (Motivational Interviewing, Control (brochure))
Completed
- Depression
- Substance-Related Disorders
- Motivational Interviewing
- Control (brochure)
-
Union City, CaliforniaKaiser Permanente Medical Center Southern Alameda County
Jun 8, 2015
G72 in Amyotrophic Lateral Sclerosis: Biomarker Discovery and
Unknown status
- Amyotrophic Lateral Sclerosis
- +2 more
- (no location specified)
Jun 20, 2011
Substance-Related Disorders Trial in West Haven (Cognitive Remediation)
Terminated
- Substance-Related Disorders
- Cognitive Remediation
-
West Haven, ConnecticutVA Connecticut Health Care System (West Haven)
Jun 17, 2009
Amyotrophic Lateral Sclerosis Trial in Burlington (Creatinine)
Completed
- Amyotrophic Lateral Sclerosis
-
Burlington, VermontUniversity of Vermont
Jun 23, 2005